The Week in Review: More CRO Consolidation

Venturepharm Lab signed a letter of intent with an unnamed “large multinational healthcare company” to form a clinical CRO joint venture; the largest 100 China pharmas are increasing their share of China drug market; China Animal Healthcare raised $45 million to expand its vaccine business; Artepharm Global announced a $10 million anti-malaria project in Africa; HEGLN (Dalian) Pharma paid $2 million to acquire a non-invasive urologic diagnostic technology; and Swedish Orphan Biovitrum partnered with Tonghua Dongbao Pharma (see story) to market each other’s products. More details… Stock Symbols: (SI: CAHC) (OTCBB: ARGC) (STO: SOBI) (SHEX: 600867)